• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Sunday, October 19, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Who should treat patients with opioid use disorder?

Bioengineer by Bioengineer
July 10, 2017
in Health
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

In a Point/Counterpoint, two doctors debate whether or not family physicians should provide medication-assisted treatment to their patients with opioid use disorder. Family physician David Loxterkamp states that family medicine, with its focus on relationships, communities, and team-based care, must be at the forefront of treating patients touched by this epidemic. Because family physicians know how to listen, care, and be present for their patients, Loxterkamp contends, they are well-qualified to treat addiction. In contrast, psychiatrist Richard Hill states that patients requiring medication assisted treatment need care from highly trained specialists in addiction medicine or addiction psychiatry who can treat both substance use disorder and co-morbid psychiatric disorders. Adding treatment for substance use disorder to the responsibilities of an already-overextended primary care workforce, Hill states, is an undue clinical burden.

Editorialists Richard Saitz and Timothy Daaleman contend that substance use disorder can only be treated successfully if primary care is a strong point of entry to care. Primary care physicians must be responsible for the initial and longitudinal care of patients with substance use disorders, and specialized services must be widely available and accessible. "Our nation will not be able to adequately respond to the current epidemic without addressing it in primary care and there is no question that the time to do it is now," they write.

###

Medication-Assisted Treatment Should Be Part of Every Family Physician's Practice: Yes
David Loxterkamp, MD, Belfast, Maine http://www.annfammed.org/content/15/4/309

Medication-Assisted Treatment Should Be Part of Every Family Physician's Practice: No
Richard R. Hill, MD, PhD, Case Western Reserve University School of Medicine
http://www.annfammed.org/content/15/4/310

Now is the Time to Address Substance Use Disorders in Primary Care
Richard Saitz, MD, MPH, FACP, DFASAM, Boston University School of Public Health Timothy P. Daaleman, DO, MPH, University of North Carolina at Chapel Hill
http://www.annfammed.org/content/15/4/306

Media Contact

Janelle Davis
[email protected]
913-906-6000 x5222
@annfammed

http://www.annfammed.org

Share12Tweet7Share2ShareShareShare1

Related Posts

Examining Gut Biomarkers for Autism Detection

October 19, 2025

Assessing Resilience and Care Skills in Oncology Nurses

October 19, 2025

Exploring Chronic Hepatitis B and Fatty Liver Proteomics

October 19, 2025

Pyrroloquinoline Quinone Alleviates Spinal Pain in Mice

October 19, 2025
Please login to join discussion

POPULAR NEWS

  • Sperm MicroRNAs: Crucial Mediators of Paternal Exercise Capacity Transmission

    1262 shares
    Share 504 Tweet 315
  • Stinkbug Leg Organ Hosts Symbiotic Fungi That Protect Eggs from Parasitic Wasps

    292 shares
    Share 117 Tweet 73
  • New Study Suggests ALS and MS May Stem from Common Environmental Factor

    125 shares
    Share 50 Tweet 31
  • New Study Indicates Children’s Risk of Long COVID Could Double Following a Second Infection – The Lancet Infectious Diseases

    103 shares
    Share 41 Tweet 26

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

New Study Reveals COVID-19 mRNA Vaccine Triggers Immune Response That Could Combat Cancer

ESMO 2025: mRNA COVID Vaccines Enhance Efficacy of Cancer Immunotherapy

Long-Term Growth Hormone Therapy Boosts Pediatric Stem Cells

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 65 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.